Cargando…

Nanomedicine for the Delivery of RNA in Cancer

SIMPLE SUMMARY: Cancer is a multifaceted, life-threatening, and genomically complex disease. The worldwide prevalence of cancer is so high that one in three people will develop cancer during their lifetime. Although the use of RNA therapy is promising to fight cancer, its efficient and safe delivery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghidini, Michele, Silva, Sandra G., Evangelista, Jessica, do Vale, Maria Luísa C., Farooqi, Ammad Ahmad, Pinheiro, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179531/ https://www.ncbi.nlm.nih.gov/pubmed/35681657 http://dx.doi.org/10.3390/cancers14112677

Ejemplares similares

Special Issue on Cancer Smart Nanomedicine
por: Pinheiro, Marina, et al.
Publicado: (2023)

Current Status of Amino Acid-Based Permeation Enhancers in Transdermal Drug Delivery
por: Pereira, Rui, et al.
Publicado: (2021)

MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2017)

Nanomedicine in pulmonary delivery
por: Mansour, Heidi M, et al.
Publicado: (2009)

Targeted Delivery of Nanomedicines
por: Kumar Khanna, Vinod
Publicado: (2012)

Overview on the complexity of androgen receptor-targeted therapy for prostate cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015)

Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2018)

Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs)
por: Teixeira, Maria C., et al.
Publicado: (2020)

Algae extracts and methyl jasmonate anti-cancer activities in prostate cancer: choreographers of ‘the dance macabre’
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2012)

Gut Microbiota in Lung Cancer: Where Do We Stand?
por: Georgiou, Konstantinos, et al.
Publicado: (2021)

TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2012)

Recent progress in fungus-derived bioactive agents for targeting of signaling machinery in cancer cells
por: Lin, Xiukun, et al.
Publicado: (2015)

MicroRNA Regulation of Telomerase Reverse Transcriptase (TERT): Micro Machines Pull Strings of Papier-Mâché Puppets
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2018)

The biological complexity of RKIP signaling in human cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015)

EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2020)

Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease
por: Shinn, Jongyoon, et al.
Publicado: (2022)

Nanocomposites as biomolecules delivery agents in nanomedicine
por: Bamburowicz-Klimkowska, Magdalena, et al.
Publicado: (2019)

Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes
por: Halim, Talha Abdul, et al.
Publicado: (2013)

Endometrial Cancer and BRCA Mutations: A Systematic Review
por: Gasparri, Maria Luisa, et al.
Publicado: (2022)

Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
por: Rommasi, Foad, et al.
Publicado: (2021)

Cancer nanomedicine: a review of recent success in drug delivery
por: Tran, Stephanie, et al.
Publicado: (2017)

Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management
por: Tagde, Priti, et al.
Publicado: (2022)

Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine
por: Wang, Qi, et al.
Publicado: (2023)

Role of nanotechnology and gene delivery systems in TRAIL-based therapies
por: Naoum, George E, et al.
Publicado: (2016)

Nanomedicines for the Delivery of Biologics
por: Wahlich, John, et al.
Publicado: (2019)

Anticancer and Anti-Metastatic Role of Thymoquinone: Regulation of Oncogenic Signaling Cascades by Thymoquinone
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

The Role and Expression of Angiogenesis-Related miRNAs in Gastric Cancer
por: Giuppi, Martina, et al.
Publicado: (2021)

Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges
por: Rizwanullah, Md., et al.
Publicado: (2021)

Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
por: Kang, Xuejia, et al.
Publicado: (2023)

Microneedles: A New Frontier in Nanomedicine Delivery
por: Larrañeta, Eneko, et al.
Publicado: (2016)

Antisense therapeutics in oncology: current status
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2014)

HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
por: Chytil, Petr, et al.
Publicado: (2021)

Localized delivery of nanomedicine and antibodies for combating COVID-19
por: Tu, Bin, et al.
Publicado: (2023)

Cancer nanomedicine
por: Bhatia, Sangeeta N., et al.
Publicado: (2022)

Nanomedicine and nanoparticle-based delivery systems in plastic and reconstructive surgery
por: Solidum, Jea Giezl N., et al.
Publicado: (2023)

Self-Assembling β-Glucan Nanomedicine for the Delivery of siRNA
por: Lee, Kyungwoo, et al.
Publicado: (2020)

Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery
por: Sun, Da, et al.
Publicado: (2019)

Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

Viruses as nanomedicine for cancer
por: Badrinath, Narayanasamy, et al.
Publicado: (2016)

Development of Drug Delivery Systems Based on Layered Hydroxides for Nanomedicine
por: Barahuie, Farahnaz, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cap8tcj9dmjgeu9bsqbjva9pk3